Evaluation of anticancer peptide VEGF111b secretion in HEK293 human cells
Background: VEGF111b is a new isoform of vascular endothelial growth factor (VEGF) recently considered as a new anticancer drug. The aim of this study was to evaluate the VEGF111b secretion from HEK293 cell wall in order to commercial production of this recombinant factor. Materials and Methods: A...
Main Authors: | Morteza Sadeghi, Zohreh Hojati |
---|---|
Format: | Article |
Language: | fas |
Published: |
Kashan University of Medical Sciences and Health Services
2017-04-01
|
Series: | Fiyz̤ |
Subjects: | |
Online Access: | http://feyz.kaums.ac.ir/article-1-3277-en.html |
Similar Items
-
Evaluation of VEGF-111b Anticancer Peptide Production in Transfected Human Cells Using Real time- PCR Analysis
by: Morteza Sadeghi, et al.
Published: (2017-02-01) -
Exposition of hepatitis B surface antigen (HBsAg) on the surface of HEK293T cell and evaluation of its expression
by: Mina Mirian, et al.
Published: (2016-01-01) -
Nanotoxic Effects of Silver Nanoparticles on Normal HEK-293 Cells in Comparison to Cancerous HeLa Cell Line
by: Liu X, et al.
Published: (2021-02-01) -
Expression Analysis of Interferon Beta Level in HEK293T Cells Using Real-Time PCR and Protein Tests
by: Raheleh Norouzi, et al.
Published: (2016-11-01) -
Affecting HEK293 Cell Growth and Production Performance by Modifying the Expression of Specific Genes
by: Laura Abaandou, et al.
Published: (2021-07-01)